RSS Feed Link

Elizabeth Iorns, PhD

Reducing Costs and Accelerating Innovation in Biotech Startups

Operating a biotech startup has presented increased difficulty and risk to entrepreneurs over the past decade. The costs of development for biotech startups have grown so much as to become a barrier to entry. Up-front capital costs for equipment now range from $200,000 for a scanning electron microscope to $740,000 for an Illumina next-generation sequencing platform (Wall Street Journal, 2012). It is in turn quite cost-prohibitive to establish in-house research platforms on basic startup funding.

[More]
Posted by: Elizabeth Iorns, PhD
on June 20, 2013
Category:  Creation 
  • 1